INDIAN BENCHMARKS are likely to start the session on a negative note as the global cues look unsupportive with SGX Nifty trading 42.00 points higher.
Headlines for the day:
Aurobindo Pharma receives USFDA approval for Raloxifene Hydrochloride
Bharti Airtel & Idea Hike Post-paid Data Tariffs By 20% In Delhi
ONGC, partners including OIL to invest $24 billion in Mozambique gas field
Trend in FII flows: The FIIs were net buyers of Rs 56.41 Cr in the cash segment on Friday while the DIIs were net buyers of Rs 847.43 Cr, as per the provisional figures released by the NSE.